Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
The Updated Results of Asciminib Managed-Access Program (MAP) in Patients with Chronic Myeloid Leukemia in RussiaKuzmina, Elena ; Chelysheva, Ekaterina ; Lomaia, Elza ; Morozova, Elena V ; Shukhov, Oleg ; Petrova, Anna ; Chitanava, Tamara ; Vlasova, Julia ; Sbitiakova, Evgenia ; Lazorko, Natalia ; Nemchenko, Irina ; Bykova, Anastasiya Vitalievna ; Gurianova, Margarita ; Kokhno, Alina ; Turkina, AnnaBlood, 2023-11, Vol.142 (Supplement 1), p.1803-1803 [Periódico revisado por pares]Texto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Results of a Single Center Survey on Vaccination Against COVID-19 in Patients with Chronic Myeloid LeukemiaChelysheva, Ekaterina Yu ; Petrova, Anna ; Shukhov, Oleg A. ; Gurianova, Margarita ; Bykova, Anastasiya ; Nemchenko, Irina ; Tsyba, Nikolay ; Kokhno, Alina V. ; Turkina, Anna G.Blood, 2021-11, Vol.138 (Supplement 1), p.4604-4604 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Humoral Immunity and Adverse Events after Vaccination Against COVID-19 By a Vector Based Vaccine Sputnik V in Patients with Chronic Myeloid LeukemiaChelysheva, Ekaterina Yu ; Petrova, Anna ; Shukhov, Oleg A. ; Gurianova, Margarita ; Bykova, Anastasiya ; Nemchenko, Irina ; Tsyba, Nikolay ; Tikhomirov, Dmitry S. ; Turkina, Anna G.Blood, 2021-11, Vol.138 (Supplement 1), p.4599-4599 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Two-Year Updated Results of Asciminib Managed-Access Program (MAP) in RussiaTurkina, Anna ; Kuzmina, Elena A. ; Lomaia, Elza ; Morozova, Elena ; Shukhov, Oleg A. ; Petrova, Anna N. ; Chitanava, Tamara ; Vlasova, Julia J. ; Chelysheva, Ekaterina Yu ; Sbityakova, Evgeniya ; Nemchenko, Irina S. ; Bykova, Anastasiya V. ; Gurianova, Margarita A. ; Kokhno, Alina V. ; Parovichnikova, Elena N.Blood, 2022-11, Vol.140 (Supplement 1), p.9654-9655 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
The Role of BCR-ABL Levels Fluctuations and Loss of Deep Molecular Response after Treatment Discontinuation in Patients with Chronic Myeloid Leukemia in the Prospective Trial RU-SKIPetrova, Anna ; Chelysheva, Ekaterina Yu ; Shukhov, Oleg A. ; Bykova, Anastasiya ; Nemchenko, Irina ; Pospelova, Olga ; Gurianova, Margarita ; Tsyba, Nikolay ; Ionova, Tatiana I. ; Turkina, Anna G.Blood, 2020-11, Vol.136 (Supplement 1), p.30-31 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
The First Results of Asciminib Therapy in Highly Pretreated Chronic Myeloid Leukemia Patients Under the Managed Access Program (MAP) in Russian FederationTurkina, Anna G. ; Shukhov, Oleg A. ; Lomaia, Elza ; Morozova, Elena V. ; Petrova, Anna ; Chelysheva, Ekaterina Yu ; Chitanava, Tamara ; Vlasova, Julia J. ; Nemchenko, Irina ; Bykova, Anastasiya ; Gurianova, Margarita ; Zaritsky, AndreyBlood, 2021-11, Vol.138 (Supplement 1), p.1483-1483 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Prognostic Model of Successful Tyrosine Kinase Inhibitors Discontinuation Based on the Russian RU-SKI Multicenter Prospective StudyShukhov, Oleg ; Chelysheva, Ekaterina ; Petrova, Anna ; Bykova, Anastasiya ; Nemchenko, Irina ; Gusarova, Galina ; Gemdzhian, Eduard ; Turkina, Anna GBlood, 2018-11, Vol.132 (Supplement 1), p.1740-1740 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
The Impact of Comorbidity on Quality of Life in Chronic Myeloid Leukemia Patients with Deep Molecular Response Who Stopped Therapy By Tyrosine Kinase Inhibitors: Results of the RU-SKI TrialIonova, Tatyana ; Nikitina, Tatiana ; Porfirieva, Natalia ; Petrova, Anna ; Chelysheva, Ekaterina Yu ; Shukhov, Oleg A. ; Bykova, Anastasiya ; Gusarova, Galina ; Nemchenko, Irina ; Tsyba, Nikolay ; Turkina, Anna G.Blood, 2019-11, Vol.134 (Supplement_1), p.2925-2925 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
PF-114 in Patients Failing Prior Tyrosine Kinase-Inhibitor Therapy Including BCR::ABL1T315ITurkina, Anna G. ; Vinogradova, Olga ; Lomaia, Elza ; Shatokhina, Evgeniya ; Shukhov, Oleg A. ; Zaritskey, Andrey ; Chelysheva, Ekaterina Yu ; Shikhbabaeva, Dzhariyat ; Nemchenko, Irina ; Petrova, Anna ; Bykova, Anastasiya ; Shuvaev, Vasily ; Siordia, Nadia ; Cortes, Jorge E. ; Gale, Robert Peter ; Baccarani, Michele ; Ottmann, Oliver ; Mikhailov, Ilya ; Novikov, Fedor ; Shulgina, Veronika ; Chilov, GhermesBlood, 2021-11, Vol.138, p.1482-1482 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
PF-114 in Patients Failing Prior Tyrosine Kinase-Inhibitor Therapy Including BCR::ABL1 T315ITurkina, Anna G. ; Vinogradova, Olga ; Lomaia, Elza ; Shatokhina, Evgeniya ; Shukhov, Oleg A. ; Zaritskey, Andrey ; Chelysheva, Ekaterina Yu ; Shikhbabaeva, Dzhariyat ; Nemchenko, Irina ; Petrova, Anna ; Bykova, Anastasiya ; Shuvaev, Vasily ; Siordia, Nadia ; Cortes, Jorge E. ; Gale, Robert Peter ; Baccarani, Michele ; Ottmann, Oliver ; Mikhailov, Ilya ; Novikov, Fedor ; Shulgina, Veronika ; Chilov, GhermesBlood, 2021-11, Vol.138 (Supplement 1), p.1482-1482 [Periódico revisado por pares]Texto completo disponível |